BRIEF published on 01/29/2026 at 00:26, 5 days 7 hours ago GenSight Biologics Reports EGM Results Shareholders Capital Increase Extraordinary General Meeting GenSight Biologics Financial Authorizations
PRESS RELEASE published on 01/29/2026 at 00:21, 5 days 7 hours ago Inside Information / Other news releases GenSight Biologics announces successful Extraordinary General Meeting approving financial authorizations renewal and clarifying rejection of 8th resolution, enhancing company's strategic flexibility Strategy Extraordinary General Meeting GenSight Biologics Gene Therapies Financial Authorizations
BRIEF published on 12/29/2025 at 08:05, 1 month 4 days ago GenSight Biologics Completes €2.9 Million Fundraising Shareholders Fundraising Gene Therapy Retinal Diseases Compassionate Use
PRESS RELEASE published on 12/29/2025 at 08:00, 1 month 4 days ago Inside Information / Other news releases GenSight Biologics successfully raises nearly €2.9 million to fund gene therapies for retinal neurodegenerative diseases, plans to use proceeds for development and operational needs through 2026 Fundraising Proceeds GenSight Biologics Gene Therapies Retinal Diseases
BRIEF published on 12/22/2025 at 07:05, 1 month 12 days ago Issuance of a compassionate access authorization for GS010/LUMEVOQ® Gene Therapy GenSight Biologics NOHL ANSM Compassionate Access
BRIEF published on 12/22/2025 at 07:05, 1 month 12 days ago GenSight Biologics Receives Compassionate Use Authorization for GS010/LUMEVOQ® in France Gene Therapy Rare Diseases Compassionate Use LHON Treatment ANSM Approval
PRESS RELEASE published on 12/22/2025 at 07:00, 1 month 12 days ago Inside Information / Other news releases GenSight Biologics receives Compassionate Use Authorization in France for GS010/LUMEVOQ® gene therapy indicated for ND4-LHON treatment France GenSight Biologics GS010/LUMEVOQ® Compassionate Use Authorization ND4-LHON
BRIEF published on 11/13/2025 at 18:02, 2 months 19 days ago Heights Capital Management crosses thresholds Convertible Bonds Crossing Thresholds Shares And Voting Rights GenSight Biologics Heights Capital
BRIEF published on 10/30/2025 at 07:35, 3 months 4 days ago GenSight Biologics: Green light for compassionate treatment in the United States FDA GenSight Biologics NOHL Compassionate Access GS010/LUMEVOQ®
BRIEF published on 09/29/2025 at 23:05, 4 months 3 days ago GenSight Biologics Announces First Half 2025 Financial Results Financial Results Research And Development Treasury GenSight Biologics Early Access Programs
Published on 02/02/2026 at 23:55, 8 hours 4 minutes ago 2026 Tunkillia Development Drilling Programs Begin
Published on 02/02/2026 at 23:55, 8 hours 4 minutes ago 55 North Mining Announces Winter Exploration Drill Program at Last Hope Gold Project
Published on 02/02/2026 at 23:25, 8 hours 34 minutes ago Western Announces Sale of GlassMasters Investment
Published on 02/02/2026 at 22:05, 9 hours 54 minutes ago Organto Foods to Attend Fruit Logistica 2026 in Berlin, Germany From February 4-6, 2026
Published on 02/02/2026 at 15:00, 16 hours 59 minutes ago Jericho Energy Ventures Strategically Terminates SmartKem LOI to Advance Independent Data Center Energy Infrastructure Platform
Published on 02/03/2026 at 07:30, 29 minutes ago Exasol Significantly Improves Results and Strengthens Business in Focus Industries – Strategic Transformation Delivers Results
Published on 02/03/2026 at 07:30, 29 minutes ago Steyr Motors with double-digit growth in 2025 and strong outlook for 2026
Published on 02/03/2026 at 07:25, 34 minutes ago Elevating Trust: Fox ESS Grand Gala 2026 Welcomes Over 300 Global Partners
Published on 02/03/2026 at 07:00, 58 minutes ago Siltronic AG with preliminary financial figures: Targets for 2025 achieved despite challenging conditions
Published on 02/03/2026 at 07:00, 59 minutes ago Sartorius Stedim Biotech achieves considerable profitable growth in 2025 and maintains positive outlook
Published on 02/02/2026 at 18:23, 13 hours 35 minutes ago Monthly disclosure of the total number of shares and voting rights - January 2026
Published on 02/02/2026 at 18:00, 13 hours 59 minutes ago Covivio - Information on total number of voting rights and share capital
Published on 02/02/2026 at 17:35, 14 hours 24 minutes ago Disclosure of transactions in own shares from January 26 to January 30, 2026
Published on 02/02/2026 at 17:22, 14 hours 37 minutes ago Statement of transactions in own shares from January 26, 2026 to January 30, 2026
